The association of insulin resistance with serum osteoprotegerin in obese adolescents

Journal of Physiology and Biochemistry

Volumn 69, Issue 4, 2013, Pages 847-853

  Suliburska, Joanna ^a   Bogdanski, Pawel ^b   Gajewska, Ewa ^b   Kalmus, Grazyna ^c   Sobieska, Magdalena ^b   Samborski, Wlodzimierz ^b  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Health Resort Hospital   (Poland)

Author keywords

Adolescents; Insulin; Obesity; Osteoprotegerin

Indexed keywords

GLUCOSE; INSULIN; OSTEOPROTEGERIN;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT CONTENT; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; OSTEOPROTEGERIN;

EID: 84888429748     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-013-0261-8     Document Type: Article

References (25)

1. Akinci B, Celtik A, Yuksel F, Genc S, Yener S, Secil M, Ozcan M, Yesil S (2011) Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. Diabetes Res Clin Pract 91:26-31
2. Akinci B, Demir T, Celtik A, Baris M, Yener S, Ozcan M, Yuksel F, Secil M, Yesil S (2008) Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. Diabetes Res Clin Pract 82:172-178
3. Ashley D, O'Sullivan E, Davenport C, Devlin N, Crowley R, McCaffrey N, Moyna N, Smith D, O'Gorman D (2011) Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. Metabolism 60:994-1000
4. Avignon A, Sultan A, Piot C, Mariano-Goulart D, Thuan Dit Dieudonné J, Cristol J, Dupuy A (2007) Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Diabetes Care 30:2934-2939
5. Gannagé-Yared M, Yaghi C, Habre B, Khalife S, Noun R, Germanos-Haddad M, Trak-Smayra V (2008) Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. Eur J Endocrinol 158:353-359
6. Jandeleit-Dahm K, Gray S (2012) Insulin and cardiovascular disease: biomarker or association? Diabetologia 55:3145-3151
7. Jeppesen J, Hansen T, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S (2007) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. Am Coll Cardiol 49:2112-2119
8. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y (2002) Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106:1192-1194
9. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J (2004) Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109:2175-2180
10. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia 28:412-419
12. Morony S, Tintut Y, Zhang Z, Cattley R, Van G, Dwyer D, Stolina M, Kostenuik P, Demer L (2008) Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation 117:411-420
13. Nikolopoulou A, Kadoglou N (2012) Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther 10:933-939
14. O'Sullivan E, Ashley D, Davenport C, Penugonda L, Kelleher G, Devlin N, Crowley R, O'Shea P, Agha A, Thompson C, O'Gorman D, Smith D (2013) A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. Metabolism 62:34-38
15. Ogden C, Carroll M, Curtin L, Lamb M, Flegal K (2010) Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 303:242-249
16. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee (1995) World Health Organ Tech Rep Ser 854:1-452
17. Reilly J, Methven E, McDowell Z, Hacking B, Alexander D, Stewart L, Kelnar C (2003) Health consequences of obesity. Arch Dis Child 88:748-752
18. Rozas Moreno P, Reyes García R, García-Martín A, Varsavsky M, García-Salcedo JA, Muñoz-Torres M (2013) Serum osteoprotegerin: bone or cardiovascular marker in type 2 diabetes males? J Endocrinol Invest 36(1):16-20
19. Schoppet M, Preissner K, Hofbauer L (2002) RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 22:549-553
20. Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Lüthy R, Nguyen H, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan H, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes T, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle W (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
21. Skelton J, Cook S, Auinger P, Klein J, Barlow S (2009) Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 9:322-329
22. Temple R, Clark PM, Hales CN (1992) Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med 9:503-512
23. Ugur-Altun B, Altun A (2007) Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women. Arch Med Res 38:891-896
24. Xiang G, Pu J, Zhao L, Sun H, Hou J, Yue L (2009) Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes. Diabet Med 26:397-403
25. Yaturu S, Rains J, Jain SK (2008) Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-a levels in men with type 2 diabetes. Cytokine 44:168-171